RGNCY-0018 (Tau phosphorylation & B-amyloid aggregation Inhibitor)

SOLD OUT!!  E-mail us at info@reagency.co if you are interested in this product.

The most important pathogenic brain changes contributing to the development of Alzheimer’s disease are the formation of the cytotoxic β -amyloid aggregates and of the neurofibrillary tangles, which originate from amyloid-β peptides and hyperphosphorylated tau protein, respectively.  Compound 8 represents a novel bis(hydroxyphenyl)-substituted thiophene that is a selective, dual inhibitors of the tau kinase Dyrk1A (IC50 = 0.5uM) and of the amyloid-β  aggregation (91+1% inhibition at 100uM).

Systematic Name: 4,4'-(thiophene-2,5-diyl)bis(2-methylphenol)


Molecular Weight: 296.38

Formula: C18H16O2S

PMID: 25247807

Reference: Mariano, Marica, et. al. "First Selective Dual Inhibitors of Tau Phosphorylation and Beta-Amyloid Aggregation, Two Major Pathogenic Mechanisms in Alzheimer’s Disease" ACS Chemical Neuroscience (2014)

Interested in this reagent? E-mail us at info@reagency.co and let us know.

Tags: Kinase, Alzheimer’s, Amyloid, Tau, Dyrk1A, Alzheimers, Alzheimer, RGNCY-0018, Phosphorylation, B-amyloid